71 results
8-K
EX-10.1
ELVN
Enliven Therapeutics Inc
18 Jun 24
Departure of Directors or Certain Officers
5:12pm
due or exercise rights of the Participant in the event of the Participant’s death or (ii) in the absence of an effective designation by a Participant … on an Award of the disability, death, termination or other cessation of employment, authorized leave of absence or other change in the employment
DEFA14A
ELVN
Enliven Therapeutics Inc
26 Apr 24
Additional proxy soliciting materials
4:11pm
. successors Election of two are Class duly elected I directors and named qualified in or the until accompanying their earlier proxy death, statement
PRE 14A
ELVN
Enliven Therapeutics Inc
15 Apr 24
Preliminary proxy
4:05pm
are duly elected and qualified or until their earlier death, resignation or removal.
To ratify the appointment of Deloitte & Touche LLP as our … statement to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death
S-4/A
u2z7 jpjk4ais2mhjgty
19 Dec 22
Registration of securities issued in business combination transactions (amended)
9:01am
S-4
EX-10.2
3oatg1aj fy
10 Nov 22
Registration of securities issued in business combination transactions
4:23pm
S-4
vkc0hy2
10 Nov 22
Registration of securities issued in business combination transactions
4:23pm
425
fyhsk09fg84 6f
13 Oct 22
Business combination disclosure
4:50pm
8-K
EX-10.4
s1tpk5i01f
13 Oct 22
Enliven Therapeutics and Imara Announce Merger Agreement
4:43pm